ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 118 filers reported holding ALLAKOS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,405 | -47.9% | 1,500 | 0.0% | 0.00% | – |
| Q2 2023 | $6,540 | -2.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2023 | $6,675 | +233.8% | 1,500 | +614.3% | 0.00% | – |
| Q4 2021 | $2,000 | -90.9% | 210 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | +22.2% | 210 | 0.0% | 0.00% | – |
| Q2 2021 | $18,000 | -100.0% | 210 | -50.0% | 0.00% | – |
| Q1 2021 | $48,208,000 | +166134.5% | 420 | +100.0% | 0.00% | -100.0% |
| Q4 2020 | $29,000 | +70.6% | 210 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | -22.7% | 210 | -32.3% | 0.00% | -100.0% |
| Q2 2020 | $22,000 | +450.0% | 310 | +210.0% | 0.00% | – |
| Q1 2020 | $4,000 | -55.6% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | -18.2% | 100 | -33.3% | 0.00% | – |
| Q3 2019 | $11,000 | +83.3% | 150 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | -14.3% | 150 | 0.0% | 0.00% | – |
| Q3 2018 | $7,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |